ADULT PATIENTS WITH ADVERSE RISK ACUTE MYELOBLASTIC LEUKEMIA

Clinical trials for ADULT PATIENTS WITH ADVERSE RISK ACUTE MYELOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new ADULT PATIENTS WITH ADVERSE RISK ACUTE MYELOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for ADULT PATIENTS WITH ADVERSE RISK ACUTE MYELOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy targets tough leukemia in older patients

Disease control Recruiting now

This early-phase trial is testing whether adding the drug daratumumab to standard chemotherapy can help adults aged 60 and older with a high-risk form of acute myeloid leukemia (AML). The main goal is to find the safest dose of daratumumab when given alongside chemotherapy. The s…

Matched conditions: ADULT PATIENTS WITH ADVERSE RISK ACUTE MYELOBLASTIC LEUKEMIA

Phase: PHASE1 • Sponsor: Nantes University Hospital • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

ADULT PATIENTS WITH ADVERSE RISK ACUTE MYELOBLASTIC LEUKEMIA

Get alerted when new ADULT PATIENTS WITH ADVERSE RISK ACUTE MYELOBLASTIC LEUKEMIA trials appear

New combo therapy targets tough leukemia in older patients